AstraZeneca announces FluMist Quadrivalent approved and available in Canada; Sinovac gets CFDA approval to start clinical trials of varicella vax;

> AstraZeneca ($AZN) Canada announced the approval and availability of FluMist Quadrivalent. Release

> Beijing-based Sinovac Dalian ($SVA) got approval from the China FDA to begin clinical trials of its varicella vaccine. Release

> Indian Immunologicals announced that its new $38 million facility to produce human and animal vaccines has begun operations. Story

Suggested Articles

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.

Since the FDA released new COVID-19 vaccine guidance, HHS Secretary Alex Azar has discussed firing FDA Commissioner Stephen Hahn, Politico reports.